About Be

Thanks to Business effiScience's approach, corporate pharmaceutical leaders can consciously make the big decisions that will shape the future of their companies, leading to maximum returns on investments in clinical or epidemiological research and to substantial increases in prescription effectiveness and OTC sales.

Healthcare - Research & Development

The HealthCare R&D Division of Business effiScience helps pharmaceutical companies identify optimal indications and minimize adverse effects for a treatment, by detecting and explaining all groups of patients - which are not detected using existing methods - who respond better than others to a given treatment, or who develop adverse effects. We also help Research institutions detect and describe unexpected local combinations of factors leading to pathologic conditions or to a significant resistance to these conditions.

Customers: Sanofi-Aventis, Servier, Ipsen, UCB, The Imperial College of London

Healthcare - Sales Force Effectiveness

The HealthCare Marketing & Sales Force Effectiveness Division of Business effiScience specifically helps pharmaceutical companies optimise the targeting of doctors. It measures the impact of marketing and sales actions based on their prescription behaviour by detecting and explaining all profit significant groups of doctors who prescribe better than others and which are not detected using existing methods.

Customers: Abbott, Amgen, BMS, Sanofi-Aventis, UCB, Organon, Janssen-Cilag